Anbio Biotechnology (NNNN) Total Current Liabilities (2023 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Total Current Liabilities of $87836.0 for Q4 2025, down 94.92% year-over-year from $1.7 million in Q4 2024, and down 100.0% quarter-over-quarter from $131.1 billion in Q2 2025.
Anbio Biotechnology (NNNN) Total Current Liabilities (2023 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Total Current Liabilities for 3 consecutive years, with $87836.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities fell 94.92% year-over-year to $87836.0; the TTM figure through Dec 2025 stood at $87836.0 (down 94.92% YoY), while the FY2025 annual figure was $87836.0, down 94.92% from the prior year.
- Total Current Liabilities slipped to $87836.0 in Q4 2025 per NNNN's latest filing, from $131.1 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $131.1 billion in Q2 2025 and bottomed at $87836.0 in Q4 2025.
- Historically, Total Current Liabilities has averaged $32.8 billion across 3 years, with a median of $1.4 million in 2023.
- Annual changes were most pronounced in 2024 — Total Current Liabilities soared 74.23% — and 2025, when it sank 94.92%.
- Anbio Biotechnology's Total Current Liabilities stood at $993060.0 in 2023, then jumped by 74.23% to $1.7 million in 2024, then tumbled by 94.92% to $87836.0 in 2025.
- Business Quant data shows NNNN's Total Current Liabilities at $87836.0 in Q4 2025, $131.1 billion in Q2 2025, and $1.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Anbio Biotechnology | 301.77 Mn | 289.87 Mn | - | 87,836.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 87,836.00 |
| Jun 30, 2025 | 131.13 Bn |
| Dec 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 993,060.00 |